Francesco Parlati
Keine laufenden Positionen mehr
Karriereverlauf von Francesco Parlati
Ehemalige bekannte Positionen von Francesco Parlati
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CALITHERA BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2015 | 01.01.2023 |
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Gründer | 01.01.2010 | 01.01.2012 |
| Corporate Officer/Principal | 01.01.2010 | 01.01.2012 | |
Proteolix, Inc.
 Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Proteolix, Inc. manufactures bio-pharmaceutical related products. It engages in the discovery, development, and marketing of pharmaceutical products to treat cancer and immunological conditions. The company was founded by Susan M. Molineauxf in December 2003 and is headquartered in South San Francisco, CA | Corporate Officer/Principal | 01.10.2009 | 01.10.2009 |
| RIGEL PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2003 | 01.12.2003 |
Ausbildung von Francesco Parlati
| McGill University | Doctorate Degree |
| Concordia University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Kanada | 3 |
Operativ
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| RIGEL PHARMACEUTICALS, INC. | Health Technology |
| CALITHERA BIOSCIENCES, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Health Technology |
Proteolix, Inc.
Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Proteolix, Inc. manufactures bio-pharmaceutical related products. It engages in the discovery, development, and marketing of pharmaceutical products to treat cancer and immunological conditions. The company was founded by Susan M. Molineauxf in December 2003 and is headquartered in South San Francisco, CA | Health Technology |
- Börse
- Insiders
- Francesco Parlati
- Erfahrung
